Literature DB >> 1939650

Sjögren-Larsson syndrome. Deficient activity of the fatty aldehyde dehydrogenase component of fatty alcohol:NAD+ oxidoreductase in cultured fibroblasts.

W B Rizzo1, D A Craft.   

Abstract

Sjögren-Larsson syndrome (SLS) is an inherited disorder associated with impaired fatty alcohol oxidation due to deficient activity of fatty alcohol:NAD+ oxidoreductase (FAO). FAO is a complex enzyme which consists of two separate proteins that sequentially catalyze the oxidation of fatty alcohol to fatty aldehyde and fatty acid. To determine which enzymatic component of FAO was deficient in SLS, we assayed fatty aldehyde dehydrogenase (FALDH) and fatty alcohol dehydrogenase in cultured fibroblasts from seven unrelated SLS patients. All SLS cells were selectively deficient in the FALDH component of FAO, and had normal activity of fatty alcohol dehydrogenase. The extent of FALDH deficiency in SLS cells depended on the aliphatic aldehyde used as substrate, ranging from 62% of mean normal activity using propionaldehyde as substrate to 8% of mean normal activity with octadecanal. FALDH activity in obligate SLS heterozygotes was partially decreased to 49 +/- 7% of mean normal activity using octadecanal as substrate. Differential centrifugation studies in fibroblasts indicated that this FALDH enzyme was largely particulate; soluble FALDH activity was normal in SLS cells. Intact SLS fibroblasts oxidized octadecanol to fatty acid at less than 10% of the normal rate, but oxidized free octadecanal normally, suggesting that the FALDH affected in SLS is chiefly involved in the oxidation of fatty alcohol to fatty acid. These results show that the primary enzymatic defect in SLS is the FALDH component of the FAO complex, which leads to deficient oxidation of fatty aldehyde derived from fatty alcohol.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1939650      PMCID: PMC295691          DOI: 10.1172/JCI115478

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  17 in total

1.  Oligophrenia in combination with congenital ichthyosis and spastic disorders; a clinical and genetic study.

Authors:  T SJOGREN; T LARSSON
Journal:  Acta Psychiatr Neurol Scand Suppl       Date:  1957

Review 2.  The disulfiram--ethanol reaction: a review.

Authors:  T M Kitson
Journal:  J Stud Alcohol       Date:  1977-01

3.  Purification and properties of a membrane-bound aldehyde dehydrogenase from rat liver microsomes.

Authors:  H Nakayasu; K Mihara; R Sato
Journal:  Biochem Biophys Res Commun       Date:  1978-07-28       Impact factor: 3.575

4.  Electrophoretic and biochemical studies of human aldehyde dehydrogenase isozymes in various tissues.

Authors:  S Harada; D P Agarwal; H W Goedde
Journal:  Life Sci       Date:  1980-05-26       Impact factor: 5.037

5.  Some properties of the fatty alcohol oxidation system and reconstitution of microsomal oxidation activity in intestinal mucosa.

Authors:  K Ichihara; E Kusunose; Y Noda; M Kusunose
Journal:  Biochim Biophys Acta       Date:  1986-10-03

6.  Reductive and oxidative synthesis of saturated and unsaturated fatty aldehydes.

Authors:  W J Ferrell; K C Yao
Journal:  J Lipid Res       Date:  1972-01       Impact factor: 5.922

7.  The interaction of acetaldehyde with tubulin.

Authors:  D J Tuma; R B Jennett; M F Sorrell
Journal:  Ann N Y Acad Sci       Date:  1987       Impact factor: 5.691

8.  Sjögren-Larsson syndrome in Sweden. A clinical, genetic and epidemiological study.

Authors:  S Jagell; K H Gustavson; G Holmgren
Journal:  Clin Genet       Date:  1981-04       Impact factor: 4.438

9.  Partitioning of long-chain alcohols into lipid bilayers: implications for mechanisms of general anesthesia.

Authors:  N P Franks; W R Lieb
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

10.  Purification of aldehyde dehydrogenase reconstitutively active in fatty alcohol oxidation from rabbit intestinal microsomes.

Authors:  K Ichihara; Y Noda; C Tanaka; M Kusunose
Journal:  Biochim Biophys Acta       Date:  1986-10-03
View more
  36 in total

1.  Molecular basis of Sjögren-Larsson syndrome: frequency of the 1297-1298 del GA and 943C-->T mutation in 29 patients.

Authors:  L Ijlst; W Oostheim; M van Werkhoven; M A Willemsen; R J Wanders
Journal:  J Inherit Metab Dis       Date:  1999-05       Impact factor: 4.982

2.  A novel assay for the prenatal diagnosis of Sjögren-Larsson syndrome.

Authors:  D M van den Brink; J M van Miert; R J A Wanders
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

3.  Large contiguous gene deletions in Sjögren-Larsson syndrome.

Authors:  Holly Engelstad; Gael Carney; Dana S'aulis; Janae Rise; Warren G Sanger; M Katharine Rudd; Gabriele Richard; Christopher W Carr; Omar A Abdul-Rahman; William B Rizzo
Journal:  Mol Genet Metab       Date:  2011-05-30       Impact factor: 4.797

4.  Confirmation of linkage of Sjögren-Larsson syndrome to chromosome 17 in families of different ethnic origins.

Authors:  M Lacour; H R Middleton-Price; J I Harper
Journal:  J Med Genet       Date:  1996-03       Impact factor: 6.318

5.  Aldehyde dehydrogenase 3 converts farnesal into farnesoic acid in the corpora allata of mosquitoes.

Authors:  Crisalejandra Rivera-Perez; Marcela Nouzova; Mark E Clifton; Elena Martin Garcia; Elizabeth LeBlanc; Fernando G Noriega
Journal:  Insect Biochem Mol Biol       Date:  2013-04-29       Impact factor: 4.714

6.  Carrier detection for Sjögren-Larsson syndrome.

Authors:  T L Kelson; D A Craft; W B Rizzo
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

7.  The molecular basis of Sjögren-Larsson syndrome: mutation analysis of the fatty aldehyde dehydrogenase gene.

Authors:  W B Rizzo; G Carney; Z Lin
Journal:  Am J Hum Genet       Date:  1999-12       Impact factor: 11.025

8.  Novel mutation in Sjogren-Larsson syndrome is associated with divergent neurologic phenotypes.

Authors:  Kathleen Davis; Kenton R Holden; Dana S'Aulis; Claudia Amador; M Gisele Matheus; William B Rizzo
Journal:  J Child Neurol       Date:  2012-10-03       Impact factor: 1.987

9.  Chlorinated lipid species in activated human neutrophils: lipid metabolites of 2-chlorohexadecanal.

Authors:  Dhanalakshmi S Anbukumar; Laurie P Shornick; Carolyn J Albert; Melissa M Steward; Raphael A Zoeller; William L Neumann; David A Ford
Journal:  J Lipid Res       Date:  2009-12-17       Impact factor: 5.922

10.  Ichthyosis in Sjögren-Larsson syndrome reflects defective barrier function due to abnormal lamellar body structure and secretion.

Authors:  William B Rizzo; Dana S'Aulis; M Anitia Jennings; Debra A Crumrine; Mary L Williams; Peter M Elias
Journal:  Arch Dermatol Res       Date:  2010-01-05       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.